Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11053246 Substituted tricyclic compounds as FGFR inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Liang Lu0

Wenqing Yao0

Chunhong He0

Colin Zhang0

Liangxing Wu0

Date of Patent

July 6, 2021

0

Patent Application Number

168425580

Date Filed

April 7, 2020

0

Patent Citations

US Patent 10738048 Bicyclic heterocycles as FGFR4 inhibitors

US Patent 10851105 Bicyclic heterocycles as FGFR4 inhibitors

US Patent 10813930 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

0

US Patent 10016348 Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB < 8, and a C

0

US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors

US Patent 10208024 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

US Patent 10213427 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

...

Patent Citations Received

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same

US Patent 11530214 Bicyclic heterocycles as FGFR inhibitors

US Patent 11566028 Bicyclic heterocycles as FGFR inhibitors

US Patent 11591329 Bicyclic heterocycles as FGFR inhibitors

US Patent 11667635 Bicyclic heterocycles as FGFR4 inhibitors

0

US Patent 11407750 Derivatives of an FGFR inhibitor

US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors

0

...

Patent Primary Examiner

0

Patent abstract

The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11053246 Substituted tricyclic compounds as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool